Top-Avocado-6991

Thanks Geert. Confused by the negativity around CVM...seems like an amazing breakthrough in cancer treatment.

Could you discuss your patent position? How much life is there to the key patents on your cancer treatment? Are there additional patents applications in the works to protect CVM assets?

Thank you. That's very helpful.

What other cancers have you identified as potential future candidates for Multikine? and do you expect to initiate studies in them at some point in the future?

Or will you get Multikine in the hands of physicians first and let them start inevitably prescribing off-label and look at results that way for future targets?

Is the silence of Cel-Sci that investors hate a simple result of the fact that you all don't care... meaning you're busy getting the actual work done, have the money to outlast the negativity and short-sellers, and will just let results speak for themselves?

Or do you have internal policy, peer-review process, or regulatory obstacles to sharing more info with investors?

Or is it that, after like 10 years trying to get through the p3 process, you simply don't have any investor relations personnel left? ;)